Clinical Trial Update: Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab in locally advanced or metastatic skin cancer has completed. The study included patients with recurrent skin carcinoma and cutane…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Skin Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Emory University | Conditions: Recurrent Skin Carcinoma, Skin Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-06-26